| Free Cash Flow |
$273.60M |
-$433.40M |
$249.30M |
-$102.60M |
$261.40M |
| -Change in Unearned Premiums |
$930.20M |
$724.00M |
$263.20M |
$641.70M |
$224.80M |
| -Change in Payables and Accrued Expense |
$356.40M |
$320.90M |
$86.00M |
$376.50M |
$151.30M |
| -Change in Accrued Investment Income |
$4.80M |
$9.00M |
-$4.90M |
-$2.40M |
-$900,000.00 |
| -Change in Deferred Acquisition Costs |
-$287.10M |
-$215.70M |
-$115.40M |
-$217.80M |
-$78.30M |
| -Change in Loss and Loss Adjustment Expense Reserves |
$149.00M |
-$43.80M |
$16.90M |
$162.50M |
$86.20M |
| -Change in Receivables |
-$778.10M |
-$860.80M |
-$139.90M |
-$681.20M |
-$14.10M |
| Change in Working Capital |
$163.60M |
-$363.90M |
$168.60M |
-$155.20M |
$238.80M |
| Deferred Tax |
$2.60M |
-$16.30M |
– |
– |
– |
| Gain/Loss from Continuing Operations |
$1.60M |
-$5.90M |
-$1.30M |
-$1.71B |
$5.90M |
| Net Income from Continuing Operations |
$108.00M |
-$42.50M |
$83.90M |
$1.73B |
$11.00M |
| Net cash flow from continuing operations |
$274.00M |
-$433.10M |
$250.20M |
-$101.70M |
$270.00M |
| Operating Cash Flow |
$274.00M |
-$433.10M |
$250.20M |
-$101.70M |
$270.00M |
| -Change in Other Current Assets |
$105.10M |
-$4.30M |
$91.30M |
-$73.30M |
-$124.60M |
| -Change in Other Current Liabilities |
$2.80M |
$7.90M |
$53.40M |
$6.80M |
$102.10M |
| -Change in Other Working Capital |
-$319.50M |
-$301.10M |
-$82.00M |
-$368.00M |
-$107.70M |
| Effect of Exchange Rate Changes |
-$900,000.00 |
$2.70M |
$1.30M |
$700,000.00 |
-$4.10M |
| Beginning Cash Balance |
$1.25B |
$946.60M |
$711.40M |
$1.41B |
$752.10M |
| Net Change in Cash |
-$184.80M |
-$21.60M |
$209.50M |
-$697.20M |
-$211.60M |
| Ending Cash Balance |
$1.06B |
$927.70M |
$922.20M |
$711.40M |
$536.40M |
| Net Other Financing Charges |
-$1.40M |
– |
$0.00 |
-$196.30M |
$0.00 |
| Cash Dividends Paid |
-$13.30M |
-$11.10M |
– |
– |
– |
| Net Common Stock Issuance |
-$219.40M |
-$22.10M |
– |
– |
– |
| Net Cash Flow from Continuing Financing Activities |
-$234.10M |
-$33.20M |
$0.00 |
-$196.30M |
$0.00 |
| Financing Cash Flow |
-$234.10M |
-$33.20M |
$0.00 |
-$196.30M |
$0.00 |
| Net Investment Purchase and Sale |
-$224.30M |
$445.00M |
-$39.80M |
-$398.30M |
-$473.00M |
| Net PPE Purchase and Sale |
-$400,000.00 |
-$300,000.00 |
-$900,000.00 |
-$900,000.00 |
-$8.60M |
| Net Cash Flow from Continuing Investing Activities |
-$224.70M |
$444.70M |
-$40.70M |
-$399.20M |
-$481.60M |
| Net cash flow from investing |
-$224.70M |
$444.70M |
-$40.70M |
-$399.20M |
-$481.60M |
No comments yet — be the first to weigh in on PLGO.